Development of orally active oxytocin antagonists: studies on 1-(1-{4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl) piperidin-4-yloxy]-2-methoxybenzoyl} piperidin-4-yl)-1, 4- …

IM Bell, JM Erb, RM Freidinger…

Index: Journal of Medicinal Chemistry, , vol. 41, # 12 p. 2146 - 2163

Full Text: HTML

Citation Number: 59

Abstract

... Journal of Medicinal ... Departments of Drug Metabolism, Medicinal Chemistry, Pharmacology, and Process Research, Merck Research Laboratories, West Point, Pennsylvania 19486 ... for preterm babies is extremely expensive, and they often incur additional medical costs resulting ...